Normal Amylase Level in Pleural Fluid
Normal pleural fluid amylase levels are defined as being at or below the upper limit of normal for serum amylase, or when the pleural fluid-to-serum amylase ratio is ≤1.0 1.
Defining Normal vs. Elevated Levels
According to the British Thoracic Society guidelines, pleural fluid amylase levels are considered elevated when they meet either of these criteria 1:
- Absolute value: Higher than the upper limits of normal for serum amylase in your laboratory
- Ratio: Pleural fluid/serum amylase ratio >1.0
Since normal serum amylase typically ranges from 30-110 U/L in most laboratories 2, normal pleural fluid amylase would generally be ≤110 U/L with a pleural fluid/serum ratio ≤1.0.
Clinical Context and Interpretation
When Normal Levels Are Expected
Normal or low pleural fluid amylase levels are found in:
- Most transudative effusions
- Most parapneumonic effusions without pancreatic involvement
- Congestive heart failure
- Post-cardiac surgery effusions (though occasional mild elevations can occur) 2
When to Measure Amylase
The guidelines are clear that routine measurement of pleural fluid amylase is NOT indicated 1. Amylase should only be measured when there is specific clinical suspicion for:
- Acute pancreatitis
- Pancreatic pseudocyst
- Esophageal rupture
- Possibly malignancy (though this is controversial)
Important Caveats
Approximately 10% of malignant effusions have elevated pleural amylase levels 1, so an elevated level does not exclude malignancy. Research shows that amylase levels >100 U/L occur in only 1.3% of all pleural effusions 2, and routine measurement has been shown to be neither clinically indicated nor cost-effective 2.
When amylase IS elevated (>100-200 U/L), isoenzyme analysis becomes critical 1:
- Pancreatic isoamylase: Suggests pancreatitis or pancreatic pseudocyst
- Salivary isoamylase: Suggests esophageal rupture or malignancy (particularly lung cancer) 3
The highest amylase levels (pleural fluid/serum ratio >10) are most specific for pancreatic disease 3, while levels in the 95th percentile (≥600 IU/L) are strongly associated with malignancy and shorter survival 4.